IN2013MU02370A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02370A
IN2013MU02370A IN2370MU2013A IN2013MU02370A IN 2013MU02370 A IN2013MU02370 A IN 2013MU02370A IN 2370MU2013 A IN2370MU2013 A IN 2370MU2013A IN 2013MU02370 A IN2013MU02370 A IN 2013MU02370A
Authority
IN
India
Prior art keywords
present
inflammation
prevention
formula
pharmaceutical composition
Prior art date
Application number
Other languages
English (en)
Inventor
Rajiv Indravadan Modi
Chandan Hardhan Singh
Niravkumar Sureshbhai Sagar
Sunilkumar Ramsuratbhai Tivari
Bipin Dhanajibhai Gadhiya
Original Assignee
Cadila Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Pharmaceuticals Ltd filed Critical Cadila Pharmaceuticals Ltd
Priority to PCT/IB2014/063031 priority Critical patent/WO2015008202A1/en
Priority to IN2370MU2013 priority patent/IN2013MU02370A/en
Priority to CA2918277A priority patent/CA2918277C/en
Priority to EP14759311.5A priority patent/EP3022177B1/en
Priority to AU2014291683A priority patent/AU2014291683B2/en
Priority to EA201690236A priority patent/EA030692B1/ru
Priority to JP2016526736A priority patent/JP6293271B2/ja
Priority to US14/904,734 priority patent/US9708258B2/en
Priority to ES14759311.5T priority patent/ES2671998T3/es
Publication of IN2013MU02370A publication Critical patent/IN2013MU02370A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IN2370MU2013 2013-07-16 2014-07-11 IN2013MU02370A (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
PCT/IB2014/063031 WO2015008202A1 (en) 2013-07-16 2014-07-11 Indole-3-carbinol derivatives
IN2370MU2013 IN2013MU02370A (es) 2013-07-16 2014-07-11
CA2918277A CA2918277C (en) 2013-07-16 2014-07-11 Indole-3-carbinol derivatives
EP14759311.5A EP3022177B1 (en) 2013-07-16 2014-07-11 Indole-3-carbinol derivatives
AU2014291683A AU2014291683B2 (en) 2013-07-16 2014-07-11 Indole-3-carbinol derivatives
EA201690236A EA030692B1 (ru) 2013-07-16 2014-07-11 Производные индол-3-карбинола
JP2016526736A JP6293271B2 (ja) 2013-07-16 2014-07-11 インドール−3−カルビノール誘導体
US14/904,734 US9708258B2 (en) 2013-07-16 2014-07-11 Indole 3-carbinol derivatives
ES14759311.5T ES2671998T3 (es) 2013-07-16 2014-07-11 Derivados de indol-3-carbinol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2370MU2013 IN2013MU02370A (es) 2013-07-16 2014-07-11

Publications (1)

Publication Number Publication Date
IN2013MU02370A true IN2013MU02370A (es) 2015-06-19

Family

ID=52345790

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2370MU2013 IN2013MU02370A (es) 2013-07-16 2014-07-11

Country Status (9)

Country Link
US (1) US9708258B2 (es)
EP (1) EP3022177B1 (es)
JP (1) JP6293271B2 (es)
AU (1) AU2014291683B2 (es)
CA (1) CA2918277C (es)
EA (1) EA030692B1 (es)
ES (1) ES2671998T3 (es)
IN (1) IN2013MU02370A (es)
WO (1) WO2015008202A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104906086A (zh) * 2015-06-24 2015-09-16 安徽四正医药科技有限公司 吲哚-3-甲醇、二吲哚甲烷及其衍生物用于治疗肾小球肾炎药物的应用
US20210353648A1 (en) * 2018-09-27 2021-11-18 Arrys Therapeutics, Inc. Grapiprant unit dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002060382A (ja) * 2000-08-22 2002-02-26 Ajinomoto Co Inc モナティンの立体異性体及びその使用、並びにモナティン類の製造方法及びそのための中間体
GB0614068D0 (en) * 2006-07-14 2006-08-23 Glaxo Group Ltd Compounds
US7807705B2 (en) * 2007-05-18 2010-10-05 The Ohio State University Research Foundation Potent indole-3-carbinol-derived antitumor agents
US8153680B2 (en) 2009-08-25 2012-04-10 The Ohio State University Research Foundation Alkyl indole-3-carbinol-derived antitumor agents

Also Published As

Publication number Publication date
AU2014291683B2 (en) 2017-11-02
US20160159740A1 (en) 2016-06-09
AU2014291683A1 (en) 2016-02-18
EA201690236A1 (ru) 2016-07-29
EA030692B1 (ru) 2018-09-28
ES2671998T3 (es) 2018-06-12
JP6293271B2 (ja) 2018-03-14
CA2918277A1 (en) 2015-01-22
CA2918277C (en) 2021-02-16
JP2016527226A (ja) 2016-09-08
EP3022177B1 (en) 2018-03-28
EP3022177A1 (en) 2016-05-25
WO2015008202A1 (en) 2015-01-22
US9708258B2 (en) 2017-07-18

Similar Documents

Publication Publication Date Title
PH12016500582A1 (en) Heterocyclic compounds and uses thereof
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
PH12017500941A1 (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
CL2016000153A1 (es) Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MY192717A (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2015016983A (es) Moduladores del transporte nuclear y usos de los mismos.
EA201691032A1 (ru) Производные изохромена в качестве ингибиторов фосфоинозитид-3-киназ
MX2016011810A (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
BR112016012146A2 (pt) Compostos derivados de aminopiridina como inibidores quinase da família tam, composição farmacêutica compreendendo ditos compostos e uso terapêutico dos mesmos
EA201692313A1 (ru) Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ
MX2016011865A (es) Composiciones farmaceuticas de compuestos terapeuticamente activos.
PH12014501078A1 (en) Pharmaceutical compositions and methods of use of 4-pregenen-11�-17-21-triol-3,20-dione derivatives
PH12016500863A1 (en) Tetracyclic autotaxin inhibitors
EA201690783A1 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
IN2013MU03641A (es)
MX2016005437A (es) Derivados de n-(1-hidroxi-3-(pirrolidinil)propan-2-il)pirrolidin-3 -carboxamida como inhibidores de glucosilceramida sintasa.
MX2016002930A (es) Moduladores del receptor x hepatico (lxr).
MX371343B (es) Moduladores del receptor x hepatico (lxr).
MX2015016603A (es) Composiciones de corticosteroides.
IN2013MU02370A (es)
EA201400444A1 (ru) Производные 2-оксопиперидинила
PH12020500472A1 (en) Autotaxin inhibitor compounds
AU2016349439A8 (en) Non-bioconvertible C3-substituted pregnenolone derivatives for use in the treatment of substance use disorders